The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Dual specificity phosphatases: a gene family for control of MAP kinase function
Abstract
Mitogen‐activated protein (MAP) kinases are important players in signal transduction pathways activated by a range of stimuli and mediate a number of physiological and pathological changes in cell function. MAP kinase activation requires phosphorylation on a threonine and tyrosine residue located within the activation loop of kinase subdomain VIII. This process is reversible even in the continued presence of activating stimuli, indicating that protein phosphatases provide an important mechanism for MAP kinase control. Dual specificity phosphatases (DSPs) are an emerging subclass of the protein tyrosine phosphatase (PTP) gene superfam‐ily, which appears to be selective for dephosphory‐lating the critical phosphothreonine and phosphoty‐rosine residues within MAP kinases. Some DSPs are localized to different subcellular compartments and moreover, certain family members appear highly selective for inactivating distinct MAP kinase iso‐forms. This enzymatic specificity is due in part to powerful catalytic activation of the DSP phosphatase after tight binding of its amino‐terminal to the target MAP kinase. DSP gene expression is induced strongly by various growth factors and/or cellular stresses, providing a sophisticated transcriptional mechanism for targeted inactivation of selected MAP kinase activities.—Camps, M., Nichols, A., Arkinstall, S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 14, 6–16(1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Genome Sequence of the Nematode C. elegans : A Platform for Investigating Biology
The C. elegans Sequencing Consortium* (1998) · Science · doi:10.1126/science.282.5396.2012 · Cited by 4,485
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
Ichijo, H., Nishida, E., Irie, K., Dijke, P. T., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., & Gotoh, Y. (1997) · Science · doi:10.1126/science.275.5296.90 · Cited by 2,307
Cowley, S. (1994) · Cell · doi:10.1016/0092-8674(94)90133-3 · Cited by 1,966
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Verheij, M., Bose, R., Hua Lin, X., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., et al. (1996) · Nature · doi:10.1038/380075a0 · Cited by 1,767
Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., & Ahn, N. G. (1994) · Science · doi:10.1126/science.8052857 · Cited by 1,353
Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
Yang, D. D., Kuan, C.-Y., Whitmarsh, A. J., Rinócn, M., Zheng, T. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1997) · Nature · doi:10.1038/39899 · Cited by 1,238
Sun, H., Charles, C. H., Lau, L. F., & Tonks, N. K. (1993) · Cell · doi:10.1016/0092-8674(93)90383-2 · Cited by 1,156
Cited by
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
Feedback Inhibition of the Unfolded Protein Response by GADD34-Mediated Dephosphorylation of eIF2α
Novoa, I., Zeng, H., Harding, H. P., & Ron, D. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1011 · Cited by 1,386
Chen, Z., Gibson, T. B., Robinson, F., Silvestro, L., Pearson, G., Xu, B.-E., Wright, A., Vanderbilt, C., & Cobb, M. H. (2001) · Chemical Reviews · doi:10.1021/cr000241p · Cited by 788
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
Owens, D. M., & Keyse, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210412 · Cited by 777
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Patterson, K. I., Brummer, T., O'brien, P. M., & Daly, R. J. (2009) · Biochemical Journal · doi:10.1042/bj20082234 · Cited by 744
Warnatz, K., Denz, A., Dräger, R., Braun, M., Groth, C., Wolff-Vorbeck, G., Eibel, H., Schlesier, M., & Peter, H. H. (2002) · Blood · doi:10.1182/blood.v99.5.1544 · Cited by 626
Redox signaling and the MAP kinase pathways
Torres, M., & Forman, H. J. (2003) · BioFactors · doi:10.1002/biof.5520170128 · Cited by 580
Dual‐specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling
Caunt, C. J., & Keyse, S. M. (2013) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08716.x · Cited by 535
Jiang, F., Zhang, Y., & Dusting, G. J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002980 · Cited by 572
Boutros, T., Chevet, E., & Metrakos, P. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.00106 · Cited by 545
Targeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses
Jeffrey, K. L., Camps, M., Rommel, C., & Mackay, C. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2289 · Cited by 533
Self-citationCombinatorial control of the specificity of protein tyrosine phosphatases
Tonks, N. K., & Neel, B. G. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00196-4 · Cited by 501
Functions and regulations of fibroblast growth factor signaling during embryonic development
Thisse, B., & Thisse, C. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.09.011 · Cited by 497
Inside the human cancer tyrosine phosphatome
Julien, S. G., Dubé, N., Hardy, S., & Tremblay, M. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2980 · Cited by 495
MAPKs and their relevance to arthritis and inflammation
Thalhamer, T., McGrath, M. A., & Harnett, M. M. (2007) · Rheumatology · doi:10.1093/rheumatology/kem297 · Cited by 460
The ERK Cascade: A Prototype of MAPK Signaling
Rubinfeld, H., & Seger, R. (2005) · Molecular Biotechnology · doi:10.1385/mb:31:2:151 · Cited by 460
Structure and regulation of MAPK phosphatases
Farooq, A., & Zhou, M.-M. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.12.008 · Cited by 451
Reactive Oxygen Species Are Signalling Molecules for Skeletal Muscle Adaptation
Powers, S. K., Duarte, J., Kavazis, A. N., & Talbert, E. E. (2010) · Experimental Physiology · doi:10.1113/expphysiol.2009.050526 · Cited by 440
The complexity of mitogen-activated protein kinases (MAPKs) made simple
Krishna, M., & Narang, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8170-7 · Cited by 432
Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., & Clark, A. R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060336 · Cited by 430
“DUSP1 is a member of a large family of MAPK phosphatases, several of which can inactivate JNK and p38 (12).”
BackgroundInfluentialFidelity and spatio-temporal control in MAP kinase (ERKs) signalling
Pouysségur, J., Volmat, V., & Lenormand, P. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01135-8 · Cited by 421
Balbi, V., & Devoto, A. (2008) · New Phytologist · doi:10.1111/j.1469-8137.2007.02292.x · Cited by 414
Flavonoids: modulators of brain function?
Spencer, J. P. E. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508965776 · Cited by 384
Jasmonates: Multifunctional Roles in Stress Tolerance
Ahmad, P., Rasool, S., Gul, A., Sheikh, S. A., Akram, N. A., Ashraf, M., Kazi, A. M., & Gucel, S. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00813 · Cited by 384
Lasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., & Clark, A. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7802-7811.2002 · Cited by 382
Roy, S. K., Srivastava, R. K., & Shankar, S. (2010) · Journal of Molecular Signaling · doi:10.1186/1750-2187-5-10 · Cited by 379
Mansouri, A., Ridgway, L. D., Korapati, A. L., Zhang, Q., Tian, L., Wang, Y., Siddik, Z. H., Mills, G. B., & Claret, F. X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208134200 · Cited by 377
Protein tyrosine phosphatases: prospects for therapeutics
Zhang, Z.-Y. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00223-4 · Cited by 348
Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336
Diverse physiological functions for dual-specificity MAP kinase phosphatases
Dickinson, R. J., & Keyse, S. M. (2006) · Journal of Cell Science · doi:10.1242/jcs.03266 · Cited by 329
Ivanov, A., Pellegrino, C., Rama, S., Dumalska, I., Salyha, Y., Ben‐Ari, Y., & Medina, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105510 · Cited by 319
NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling
Paul, S., Nairn, A. C., Wang, P., & Lombroso, P. J. (2003) · Nature Neuroscience · doi:10.1038/nn989 · Cited by 314
Elad-Sfadia, G., Haklai, R., Balan, E., & Kloog, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312697200 · Cited by 305
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Oncogenic Ras in tumour progression and metastasis
Giehl, K. (2005) · Biological Chemistry · doi:10.1515/bc.2005.025 · Cited by 287
Replicative senescence: a critical review
Cristofalo, V. J., Lorenzini, A., Allen, R. G., Torres, C., & Tresini, M. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.07.010 · Cited by 274
Li, C., Scott, D. A., Hatch, E., Tian, X., & Mansour, S. L. (2007) · Development · doi:10.1242/dev.02701 · Cited by 273
The interactions of flavonoids within neuronal signalling pathways
Spencer, J. P. E. (2007) · Genes & Nutrition · doi:10.1007/s12263-007-0056-z · Cited by 270
Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1
Jeffrey, K. L., Brummer, T., Rolph, M. S., Liu, S. M., Callejas, N. A., Grumont, R. J., Gillieron, C., Mackay, F., Grey, S., Camps, M., et al. (2006) · Nature Immunology · doi:10.1038/ni1310 · Cited by 270
Self-citationRegulation of MAP kinases by MAP kinase phosphatases
Kondoh, K., & Nishida, E. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.12.002 · Cited by 268
DUSPs, to MAP kinases and beyond
Huang, C.-Y., & Tan, T.-H. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-24 · Cited by 260
O'Flaherty, C., de Lamirande, E., & Gagnon, C. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.027 · Cited by 260
Dexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38
Lasa, M., Brook, M., Saklatvala, J., & Clark, A. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.771-780.2001 · Cited by 259
Berset, T., Hoier, E. F., Battu, G., Canevascini, S., & Hajnal, A. (2001) · Science · doi:10.1126/science.1055642 · Cited by 257
Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5
Zhang, Y., Blattman, J. N., Kennedy, N. J., Duong, J., Nguyen, T., Wang, Y., Davis, R. J., Greenberg, P. D., Flavell, R. A., & Dong, C. (2004) · Nature · doi:10.1038/nature02764 · Cited by 253
Sharma, S. D., Meeran, S. M., & Katiyar, S. K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0661 · Cited by 219
Chronic activation of ERK and neurodegenerative diseases
Colucci‐D'Amato, L., Perrone‐Capano, C., & di Porzio, U. (2003) · BioEssays · doi:10.1002/bies.10355 · Cited by 195
“The phosphatases MKP-3 and MKP-1 display opposite subcellular localization, in the cytoplasm and in the nucleus, respectively.((8)) They are dual specificity phosphatases (DSPs), a subclass of protein tyrosine phosphatases, which selectively dephosphorylate the critical phosphothreonine and phosphotyrosine residues wi…”
BackgroundRoger, T., Chanson, A., Knaup‐Reymond, M., & Calandra, T. (2005) · European Journal of Immunology · doi:10.1002/eji.200535413 · Cited by 184
Molecular Pathways and Mechanisms of BRAF in Cancer Therapy
Poulikakos, P. I., Sullivan, R. J., & Yaeger, R. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2138 · Cited by 145
Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3
Liu, S., Sun, J.-P., Zhou, B., & Zhang, Z.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510506103 · Cited by 140
Docking interactions in the mitogen-activated protein kinase cascades
Tanoue, T., & Nishida, E. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00188-2 · Cited by 134
Gao, Y., Liu, F., Fang, L., Cai, R., Zong, C., & Qi, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096741 · Cited by 110
Transcriptional networks and cellular senescence in human mammary fibroblasts.
Hardy, K., Mansfield, L., Mackay, A., Benvenuti, S., Ismail, S., Arora, P., O'Hare, M. J., & Jat, P. S. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-05-0392 · Cited by 71
Zhang, Y.-Y., Wu, J.-W., & Wang, Z.-X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203786 · Cited by 63
Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis
Paunovic, V., & Harnett, M. M. (2013) · Drugs · doi:10.1007/s40265-013-0014-6 · Cited by 61
Gene expression alterations in activated human T-cells induced by modeled microgravity
Ward, N. E., Pellis, N. R., Risin, S. A., & Risin, D. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20988 · Cited by 47
BARDWELL, L., & SHAH, K. (2006) · Methods · doi:10.1016/j.ymeth.2006.06.008 · Cited by 46
Feng, B., He, Q., & Xu, H. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.001 · Cited by 37
Tárrega, C., Blanco-Aparicio, C., Muñoz, J. J., & Pulido, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108874200 · Cited by 33
Crystal structure of the MAP kinase binding domain and the catalytic domain of human MKP5
Tao, X., & Tong, L. (2007) · Protein Science · doi:10.1110/ps.062712807 · Cited by 31
“MAP kinase phosphatases (MKPs) are important regulators of MAP kinase signaling, by dephosphorylating activated MAP kinases (Camps et al. 1999; Theodosiou and Ashworth 2002; Farooq and Zhou 2004; Martin et al. 2005; Dickinson and Keyse 2006).”
BackgroundOkamura, J., Huang, Y., Moon, D., Brait, M., Chang, X., & Sook-Kim, M. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.3.18695 · Cited by 28
Molecular Determinants of Substrate Recognition in Hematopoietic Protein-tyrosine Phosphatase
Huang, Z., Zhou, B., & Zhang, Z.-Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407820200 · Cited by 23
Metadata
- Authors
- CAMPS, M., NICHOLS, A., & ARKINSTALL, S.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-01
- Volume
- 14
- Issue
- 1
- Pages
- 6-16
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2111305451
- Cited by
- 811
- References
- 88
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.